Found 8 results

2010
ADVANCE Collaborative Group, Writing Committee, Kengne AP, Patel A, Colagiuri S, Heller S, Hamet P, Marre M, Pan CY, Zoungas S et al..  2010.  The Framingham and UK Prospective Diabetes Study (UKPDS) risk equations do not reliably estimate the probability of cardiovascular events in a large ethnically diverse sample of patients with diabetes: the Action in Diabetes and Vascular Disease: Preterax. Diabetologia. Epub. [IF 6.418]
2009
ADVANCE Collaborative Group, Writing Committee, Ninomiya T, Perkovic V, de Galan B, Zoungas S, Pillai A, Jardine M, Patel A, Cass A et al..  2009.  Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes. J Am Soc Nephrol. 20:1813-21.[IF7.111]..
ADVANCE Collaborative Group, Writing Committee, Zoungas S, de Galan BE, Ninomiya T, Grobbee D, Hamet P, Heller S, Macmahon S, Marre M et al..  2009.  The combined effects of routine blood pressure lowering and intensive glucose control on macrovascular and microvascular outcomes in patients with type 2 diabetes; new results from ADVANCE. Diabetes Care. 32:2068-74.[IF7.349].
ADVANCE Collaborative Group, de Galan BE, Perkovic V, Ninomiya T, Pillai A, Patel A, Cass A, Neal B, Poulter N, Harrap S et al..  2009.  Routine blood pressure lowering and kidney disease in type 2 diabetes. J Am Soc Nephrol. 20:883-92.[IF7.111].
2008
ADVANCE Collaborative Group Writing Group, (Writing Committee), Patel A, MacMahon S, Chalmers J, Neal B, Billot L, Woodward M, Marre M, Cooper M et al..  2008.  Intensive blood glucose control on vascular outcomes in patients with type 2 diabetes . N Engl J Med . 358:2560-72.[IF52.589][Grant:ADVANCE&ProgramGrant].
Chalmers J, [Contributing authors], Colagiuri S, Cooper M, Grobbee R, Hamet P, Kengne A-P, MacMahon S, Marre M, Mogensen C-E et al..  2008.  Prevention of vascular outcomes in type 2 diabetes: benefits of intensive blood pressure and blood glucose control with Preterax and Diamicron MR, Issue III.
Chalmers J, contributing authors, Colagiuri S, Cooper M, Grobbee R, Hamet P, Kengne AP, MacMahon S, Marre M, Mogensen CE et al..  2008.  Prevention of vascular outcomes in type 2 diabetes: benefits of intensive blood pressure and blood glucose control with Preterax and Diamicron MR. Issue III.
2007
Patel A, ADVANCE Collaborative Group, (Writing Committee), MacMahon S, Chalmers J, Neal B, Woodward M, Billot L, Harrap S, Poulter N et al..  2007.  Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. Lancet . 370:829-40.[IF28.638].

Latest news

Recently added pages

Our focus

George Institute sites